Clinical Trial Update: A Screening Study Evaluating Disease Status of Gaucher Type I Patients

View source ↗

Summary

A screening study evaluating disease status in Gaucher disease type 1 patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease Type

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Gaucher Disease, Type 1 | Status: WITHDRAWN